Anna Trask serves as Executive at Decibel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Anna Trask has executed 9 insider transactions totaling $120.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 25, 2023 involved selling 106,864 shares valued at $0.
Anna Trask currently holds 106,864 shares of Decibel Therapeutics, Inc. (DBTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anna Trask has been a net seller of DBTX stock. They have purchased $0 and sold $120.1K worth of shares.
Anna Trask's most recent insider trade was on Sep 25, 2023, when they sold 106,864 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 3, 2022 | DBTX | $1.9K | Sale | 377 | $5.03 | Discretionary |
| Jan 3, 2022 | DBTX | $5 | Sale | 1 | $5.04 | Discretionary |
| Dec 2, 2021 | DBTX | $31.3K | Sale | 4,913 | $6.37 | Discretionary |
| Dec 2, 2021 | DBTX | $2.4K | Sale | 378 | $6.34 | Discretionary |
| Nov 3, 2021 | DBTX | $3.2K | Sale | 378 | $8.34 | Discretionary |
| Nov 2, 2021 | DBTX | $40.8K | Sale | 4,913 | $8.31 | Discretionary |
| Oct 14, 2021 | DBTX | $40.5K | Sale | 5,364 | $7.55 | Discretionary |